According to the latest report by IMARC Group, titled “Animal Model Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global animal model market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 6% during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Report Sample: https://www.imarcgroup.com/animal-model-market/requestsample
An animal model is a non-human and genetically engineered species used for medical investigation and research of a disease. Mice, guinea pigs, rabbits, gerbils, hamsters and rats are some commonly utilized animal models. They are also used in obtaining information regarding the diagnosis, treatment and prevention of various neurological and physiological disorders. Numerous technologies, such as nuclear transfer and embryonic stem cell injection, are used to analyze the changes in animal models. They aid in providing comprehensive insights of various chronic diseases and are highly cost-effective and can be maintained in-house. They find extensive application for medical research and drug discovery and development in pharmaceutical organizations and academic research institutions.
The global animal model market is primarily being driven by the rising prevalence of genetic disorders among the masses. There is a shifting consumer preference toward personalized medicines, which is leading to the increasing utilization of animal models in pre-clinical trials for the development of drugs. Moreover, various technological advancements, such as the introduction of clustered regularly interspaced short palindromic repeats (CRISPR) technology, which aids in producing novel drugs with enhanced efficacy, are providing a thrust to the market growth. Other factors, including significant investments in improving the medical infrastructure, along with extensive research and development (R&D) activities in the field of biotechnology, are anticipated to drive the market toward growth.
Animal Model Market 2021-2026 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the global animal model market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Biocytogen
- Charles River Laboratories International Inc
- Envigo
- Eurofins Scientific SE
- GenOway S.A.
- Hera BioLabs
- JSR Corporation
- Ozgene Pty Ltd.
- PerkinElmer Inc.
- Taconic Biosciences Inc.
- The Jackson Laboratory
- Trans Genic Inc.
Key Market Segmentation:
The report has segmented the global animal model market on the basis of animal type, technology, application, end user and region.
Breakup by Animal Type:
- Rat
- Mice
- Guinea Pigs
- Rabbits
- Others
Breakup by Technology:
- CRISPR
- Embryonic Stem Cell Injection
- Nuclear Transfer
- Others
Breakup by Application:
- Drug Discovery and Development
- Basic Research
- Others
Breakup by End User:
- Pharma and Biotech Companies
- Academic Research Institutes
- Others
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/animal-model-market
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Industry Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
